Immuron (IMRN) Free Cash Flow (2016 - 2024)
Immuron's (IMRN) quarterly Free Cash Flow came in at -$2.6 million in Q4 2024, down 100.19% year-on-year from $1.3 billion in Q1 2024, and down 100.19% quarter-over-quarter from -$1.3 million in Q4 2023.
Immuron (IMRN) Free Cash Flow (2016 - 2024) Analysis & Trends
Immuron's Free Cash Flow history runs 9 years deep, the most recent figure standing at -$2.6 million for Q4 2024.
- On a quarterly basis, Free Cash Flow fell 100.19% year-over-year to -$2.6 million in Q4 2024; TTM through Sep 2025 was -$2.6 million, a 100.19% decrease from a year earlier, with the FY2025 full-year figure at -$3.1 million, up 47.27% from the prior year.
- Free Cash Flow declined to -$2.6 million in Q4 2024 per IMRN's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $6332.7 in Q4 2021 and bottomed at -$3.1 million in Q2 2021.
- The 5-year median for Free Cash Flow is -$2.0 million (2023), against an average of -$1.7 million.
- Across the five-year window, Free Cash Flow jumped 100.23% in 2021 and slumped 98291.95% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$2.7 million in 2020, then soared by 100.23% to $6332.7 in 2021, then tumbled by 79.02% to $1328.5 in 2022, then tumbled by 98291.95% to -$1.3 million in 2023, then tumbled by 100.19% to -$2.6 million in 2024.
- Per Business Quant, the three latest IMRN Free Cash Flow figures stand at -$2.6 million (Q4 2024), -$1.3 million (Q4 2023), and -$2.0 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Jun 30, 2023 | -2.01 Mn |
| Jun 30, 2023 | -2.01 Mn |
| Dec 31, 2022 | 1,328.50 |
| Dec 31, 2022 | 1,328.50 |
| Jun 30, 2022 | -1.90 Mn |
| Jun 30, 2022 | -1.90 Mn |
| Dec 31, 2021 | 6,332.69 |
| Dec 31, 2021 | 6,332.69 |
| Jun 30, 2021 | -3.11 Mn |
| Jun 30, 2021 | -3.11 Mn |
| Dec 31, 2020 | -2.70 Mn |
| Dec 31, 2020 | -2.70 Mn |
| Jun 30, 2020 | -2.07 Mn |
| Jun 30, 2020 | -2.07 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2019 | -1.56 Mn |